Ipsen Announces Phase III BOLD Results for Bylvay in Biliary Atresia
PARIS, France, July 24, 2026 Ipsen announced that its Phase III BOLD clinical trial evaluating Bylvay® (odevixibat) in patients...
Bylvay
Advertisement
Health Canada Approves Bylvay for Cholestatic Pruritus in ALGS
OTTAWA, Canada, September 9, 2025 — Health Canada has granted approval to Bylvay™ (odevixibat) for the treatment of cholestatic...
Advertisement
